Intensity Therapeutics, Inc.
INTS
$1.85
-$0.01-0.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.27M | -16.26M | -15.08M | -13.81M | -10.54M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 146.00K | 159.00K |
| Total Other Non-Cash Items | 3.15M | 2.70M | 2.54M | 4.56M | 3.81M |
| Change in Net Operating Assets | -2.10M | 59.00K | -2.11M | -1.57M | -633.00K |
| Cash from Operations | -15.22M | -13.50M | -14.65M | -10.67M | -7.21M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.35M | 9.18M | -2.77M | -2.76M | -6.02M |
| Cash from Investing | 6.35M | 9.18M | -2.77M | -2.76M | -6.02M |
| Total Debt Issued | -- | -13.00K | -13.00K | 25.00K | 230.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.55M | 506.00K | 22.49M | 22.48M | 22.48M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -653.00K | -82.00K | -1.95M | -2.23M | -2.23M |
| Cash from Financing | 2.90M | 411.00K | 20.52M | 20.28M | 20.47M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.97M | -3.91M | 3.11M | 6.84M | 7.24M |